Kyverna Therapeutics, Inc. Ratios

Ratios Dec2023 Dec2024
Profitability
EBT Margin 32,251.87%89,709.15%
EBIT Margin 33,372.19%100,425.35%
EBITDA Margin 33,372.19%100,425.35%
Operating Margin 33,372.19%100,425.35%
Net Margin 32,251.87%89,709.15%
FCF Margin 28,358.82%82,045.77%
Leverage & Solvency
Interest Coverage Ratio -333.72-0.00M
Times Interest Earned -333.72-0.00M
Valuation
Enterprise Value 161.46M
Market Capitalization 161.46M
Return Ratios
Return on Sales 322.52%897.09%